Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology
Visualitza/Obre
10.1016/j.actbio.2016.07.038
Inclou dades d'ús des de 2022
Cita com:
hdl:2117/102175
Tipus de documentArticle
Data publicació2016-10-01
Condicions d'accésAccés obert
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement-NoComercial-SenseObraDerivada 3.0 Espanya
Abstract
Inclusion bodies (IBs) are protein-based nanoparticles formed in Escherichia coli through stereospecific aggregation processes during the overexpression of recombinant proteins. In the last years, it has been shown that IBs can be used as nanostructured biomaterials to stimulate mammalian cell attachment, proliferation, and differentiation. In addition, these nanoparticles have also been explored as natural delivery systems for protein replacement therapies. Although the production of these protein-based nanomaterials in E. coli is economically viable, important safety concerns related to the presence of endotoxins in the products derived from this microorganism need to be addressed. Lactic acid bacteria (LAB) are a group of food-grade microorganisms that have been classified as safe by biologically regulatory agencies. In this context, we have demonstrated herein, for the first time, the production of fully functional, IB-like protein nanoparticles in LAB. These nanoparticles have been fully characterized using a wide range of techniques, including field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, zymography, cytometry, confocal microscopy, and wettability and cell coverage measurements. Our results allow us to conclude that these materials share the main physico-chemical characteristics with IBs from E. coli and moreover are devoid of any harmful endotoxin contaminant. These findings reveal a new platform for the production of protein-based safe products with high pharmaceutical interest.
CitacióCano, O., Sanchez, A., Parés, S., Giró, I., Tatkiewicz, W., Ferrer-Miralles, N., Ratera, I., Natalello, A., Cubarsi, R., Veciana, J., Bach, A., Villaverde, A., Aris, A., García, E. Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology. "Acta biomaterialia", 1 Octubre 2016, vol. 43, p. 230-239.
ISSN1742-7061
Versió de l'editorhttp://www.sciencedirect.com/science/article/pii/S1742706116303725
Col·leccions
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
acta_biomaterialia2016.pdf | 2,413Mb | Visualitza/Obre |